|
|||||
|
|
Growth of poorly differentiated endometrial carcinoma is inhibited by combined action of medroxyprogesterone acetate and the Ras inhibitor Salirasib |
|
| Authors: | Raya Faigenbaum Roni Haklai Gilad Ben-Baruch Yoel Kloog |
| Institution: | 1. Department of Neurobiology, The George S. Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv, Israel;2. Department of Obstetrics and Gynecology, Sheba Medical Center, Tel Hashomer, Sackler School of Medicine,Tel Aviv University, Tel Aviv, Israel |
| Abstract: | |
| Keywords: | Endometrial cancer medroxyprogesterone acetate FTS Ras ERα ERβ |